PMID: 8953658Nov 1, 1996Paper

Residual symptoms and P300 in schizophrenic outpatients

Psychiatry Research
G JuckelU Hegerl

Abstract

A reduced P300 amplitude has often been found to be related to schizophrenic psychopathology. It is still unclear, however, whether this relationship is trait- or state-dependent. We investigated 88 stabilized schizophrenic outpatients during a 2-year follow-up period. Multivariate analyses revealed that patients who had reduced P300 amplitudes showed pronounced residual symptoms, especially thought disorder (Brief Psychiatric Rating Scale). Intraindividual changes in that psychopathology were not correlated to corresponding changes of the P300 amplitude, so the relationship between schizophrenic psychopathology and P300 amplitude appears to be, at least in part, trait-dependent. A reduced P300 amplitude may characterize a subgroup of schizophrenic patients with a disposition to cognitive disturbances and incomplete remissions.

References

Jul 1, 1992·Annals of the New York Academy of Sciences·J M FordW Roth
Jan 1, 1992·Schizophrenia Bulletin·R M MurrayS W Lewis
Dec 1, 1992·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·S HayashidaT Sasaki
Dec 1, 1992·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·J P Laurent, J Baribeau
Jan 1, 1991·Schizophrenia Bulletin·T Van PuttenN Chabert
May 1, 1991·Electroencephalography and Clinical Neurophysiology·J M Ford, A Pfefferbaum
Dec 1, 1991·Schizophrenia Research·Y KidogamiT Sakai
Apr 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P B WardN McConaghy
Jan 1, 1990·Schizophrenia Bulletin·R C JosiassenC Shagass
Jan 1, 1989·Journal of Psychiatric Research·D St ClairW Muir
Jul 1, 1986·Psychological Bulletin·W S Pritchard
Feb 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·D H BlackwoodA McInnes
Mar 15, 1989·Biological Psychiatry·M WagnerR R Engel
Aug 1, 1988·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·S GalderisiD Kemali
Oct 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·A RomaniV Cosi
Apr 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·K BarrettP V Pocock
Feb 1, 1980·Electroencephalography and Clinical Neurophysiology·W T RothB S Kopell
Apr 1, 1981·Psychiatry Research·W T RothB S Kopell
Jul 1, 1993·Electroencephalography and Clinical Neurophysiology·K K VescoJ Polich
May 1, 1993·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·K DujardinJ D Guieu

❮ Previous
Next ❯

Citations

Jan 23, 1999·Biological Psychiatry·T Frodl-BauchU Hegerl
Mar 8, 2000·Biological Psychiatry·D H MathalonA Pfefferbaum
Oct 24, 2002·Journal of Psychiatric Research·Paraskevi MavrogiorgouUlrich Hegerl
Sep 11, 1999·Psychiatry Research·S PallantiA Pazzagli
Feb 19, 2002·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Thomas FrodlUlrich Hegerl
Jun 18, 2002·Neuroscience Research·Kiyoto KasaiMasato Fukuda
Jun 23, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·A IwanamiK Kamijima
May 10, 2001·Schizophrenia Research·T FrodlU Hegerl
Apr 17, 2002·Schizophrenia Research·D H NiemanB W Ongerboer de Visser
Mar 9, 2000·Schizophrenia Research·B KaroumiM Saoud
Apr 29, 2000·Schizophrenia Research·A IwanamiK Kamijima
Apr 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Charalabos PapageorgiouGeorge N Christodoulou
Jan 6, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christoph MulertDan Rujescu
Dec 1, 2006·Schizophrenia Bulletin·Bruce I TuretskyNeal R Swerdlow
Jul 27, 2007·The International Journal of Neuroscience·Eiji Kirino
Mar 23, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·E-Jin ParkYang-Whan Jeon
Jun 12, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Patrik RoserAndreas M Stadelmann
Sep 25, 2007·Psychiatry Research·Susan M WoodJocelyn B Ulanday
Dec 31, 2003·Psychophysiology·Yang-Whan Jeon, John Polich
Oct 6, 1999·Comprehensive Psychiatry·S PallantiA Pazzagli
Jul 13, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Susan M WoodChaiyapoj Netsiri
May 4, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Milena KorostenskajaSeppo Kähkönen
Mar 6, 2007·Psychopathology·Hanns Jurgen KunertPaul Hoff
Feb 27, 2007·Clinical EEG and Neuroscience·Oliver PogarellUlrich Hegerl
Feb 16, 2006·The Journal of Nervous and Mental Disease·Eiji Kirino
Jul 21, 2004·Clinical EEG and Neuroscience·Eiji Kirino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.